These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38664689)

  • 1. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
    Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
    Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
    Doosti A; Mokhtari-Farsani A
    Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection.
    Mah R; Locher K; Steiner TS; Stefanovic A
    Anaerobe; 2023 Aug; 82():102755. PubMed ID: 37406762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
    Chang FC; Liu CP; Sun FJ; Lin CC
    J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of community-onset Clostridioides difficile infections at a tertiary hospital in mainland China: A fourteen-year (2010-2023) retrospective study.
    Jiang X; Bian J; Lv T; Zheng L; Zhao Y; He J; Chen Y
    Int J Med Microbiol; 2024 Sep; 316():151631. PubMed ID: 39024723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
    Dubberke ER; Reske KA; Hink T; Kwon JH; Cass C; Bongu J; Burnham CD; Henderson JP
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1330-1333. PubMed ID: 30226126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
    Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of
    Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.
    Rüssmann H; Panthel K; Bader RC; Schmitt C; Schaumann R
    Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):115-9. PubMed ID: 17211606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
    Kumar S; Pollok R; Muscat I; Planche T
    J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.